ALARM ACT ONE-PAGE ADVOCACY BRIEF

3/15/2025 UPDATE – For the time being, the ALARM ACT initiative has been merged with HB 788, which was filed by Representative Kim Moser in the Kentucky General Assembly. For more information check out the KYSAM advocacy HB 788 website:  https://www.kysam.org/news

Kentucky House Bill 788 supports increased access to buprenorphine by empowering Kentucky’s providers to treat patients with evidence-based care. Check out this 9 minute video of Dr. Murphy’s recent testimony in Kentucky’s capital city: https://www.youtube.com/watch?v=3lILI0x4TXo

The salient issues remain consistent with the ALARM ACT initiative, thus I’m keeping this post on the website to provide historical context supporting our efforts to save lives.

ALARM Act one-page advocacy brief

On average, FIVE Kentuckians die every day from overdose – about 2000 deaths per year.

Overdose is the #1 cause of death for Kentuckians under the age of forty.

Every one of these deaths is PREVENTABLE.

• While Narcan may reverse an overdose, it does not treat the underlying cause of the overdose.

• In contrast, buprenorphine stabilizes brain regions that cause addictions & cause overdoses.

• Thus, buprenorphine (sometimes called Suboxone) is highly effective at PREVENTING overdoses.

• In fact, better access to buprenorphine could cut Kentucky’s overdose rate by 50% or more.

• And buprenorphine decreases drug diversion, illicit drug use, and drug-related crime.

• In sum, buprenorphine helps people achieve sustained recovery and lead healthy productive lives.

But there are barriers in the way of Kentuckians’ access to buprenorphine treatment.  The barriers include: (1stigma born of prejudice & misunderstanding, (2unfounded fear of diversion, (3) excessive costs from unnecessary regulatory requirements, and (4burdensome administrative hoops. 

KY’s buprenorphine regulation 201 KAR 9:270 is a major regulatory barrier.

Frankly, the mandates in 201 KAR 9:270 are inconsistent with clinical evidence, expert opinion, or even the DEA – and even when 201 KAR 9:270 is repealed, the DEA will continue to regulate buprenorphine like any other schedule three controlled medication. But for now, 201 KAR 9:270 still exists and contributes to the fact that only 1 in five people who need treatment with buprenorphine can access the medication.

Can you imagine restricting treatment of cancer, diabetes, or any other disease in such a callous way?

The ALARM Act is backed by the Kentucky Society of Addiction Medicine, along with a vast majority of professional societies, scientists, scholars, medical school professors, physicians, caregivers, and countless other Kentuckians affected by the disease of opioid addiction.  The ALARM Act repeals 201 KAR 9:270 and empowers Kentucky doctors to treat their patients with evidence-based medication, saving valuable healthcare resources and, most importantly,  saving precious lives.  Please support the ALARM Act. 

More information can be found via the Kentucky Society of Addiction Medicine’s website: KYSAM.ORG

James Patrick Murphy, MD

doctormurphyglms@gmail.com  

1/29/2025

Sound the ALARM ! 

3/15/2025 UPDATE – For the time being, the ALARM ACT initiative has been merged with HB 788, which was filed by Representative Kim Moser in the Kentucky General Assembly. For more information check out the KYSAM advocacy HB 788 website:  https://www.kysam.org/news

Kentucky House Bill 788 supports increased access to buprenorphine by empowering Kentucky’s providers to treat patients with evidence-based care. Check out this 9 minute video of Dr. Murphy’s recent testimony in Kentucky’s capital city: https://www.youtube.com/watch?v=3lILI0x4TXo

The salient issues remain consistent with the ALARM ACT initiative, thus I’m keeping this post on the website to provide historical context supporting our efforts to save lives.

On average, overdose kills five Kentuckians every single day.

There is something simple you can do today to help.

A brief call to your legislators, asking them to support the ALARM Act, could help save thousands of lives.

The ALARM Act is a legislative initiative aimed at improving access to buprenorphine – a lifesaving medication to treat opioid addiction – in fact, buprenorphine is our MOST EFFECTIVE measure to decrease overdoses and overdose deaths. The ALARM Act repeals regulation 201 KAR 9:270 – a decade-old KY law that severely hampers our doctors’ ability to prescribe buprenorphine.

Simply dial (800) 372-7181, and your message will be forwarded to your representatives.

You might say something to the effect of: Please help patients get the lifesaving medicine they need to treat addiction and prevent overdose deaths. Please support Dr. James Patrick Murphy and the Kentucky Society of Addiction Medicine by passing the ALARM Act, which repeal KY’s restrictive buprenorphine regulation 201 KAR 9:270.

Thanks! Now that you know my “ask,” please read on for the rest of the story

IN RECORD NUMBERS, KENTUCKIANS CONTINUE TO DIE FROM OPIOIDS.

Widespread availability of buprenorphine could decrease overdose deaths by 50% or more. Buprenorphine (sometimes know by the trade name Suboxone) is FDA-approved to treat damaged areas in the brain that cause opioid addiction and can prevent dangerous addictive behaviors that lead to overdose.

Distinct from NARCAN – which might reverse an overdose but does not treat the actual addiction –buprenorphine treats the root cause of the overdose. Buprenorphine promotes recovery, reduces crime, prevents overdoses, and saves lives.

Buprenorphine treatment is not simply trading one drug dependency for another. Quite the opposite, buprenorphine is a prescription medicine that treats the disease process, allowing patients to lead productive heathy lives – in much the same way that insulin allows people with diabetes to manage their disease and live well.

Tragically, barriers to accessing buprenorphine exist, such as regulatory burdens, costs, stigma, and unfounded fear of diversion. Thus, only one in five Kentuckians who need buprenorphine can get treatment.

In Kentucky, a major barrier to buprenorphine treatment is 201 KAR 9:270 – an obsolete law that is not aligned with current clinical evidence. This onerous regulation restricts effective dosing and forces doctors and patients to complete costly, unnecessary tasks and imposes unscientific mandates that contradict recommendations of the overwhelming majority of experts. This is beyond illogical – it’s dangerous and deprives suffering people of lifesaving medication.

Ask yourself, would anyone be OK with treating breast cancer this way? Of course not. So why is Kentucky so restrictive with treating ADDICTION ? – the #1 cause of death for adults under the age of forty.

Kentucky is a an outlier. Our federal government and most other states have already done away with antiquated regulations like 201 KAR 9:270, allowing buprenorphine to be regulated like any other DEA schedule 3 controlled substance – as it should be. But Kentucky, despite ranking among the absolute worst states in terms of overdose deaths, somehow is still hanging on to 201 KAR 9:270. This must change. The regulation must be repealed.

The ALARM Act is a vital grass roots legislative initiative, supported by the Kentucky Society of Addiction Medicine and many others, that will repeal 201 KAR 9:270 and allow all Kentucky doctors to confidently treat their patients with buprenorphine – the “gold standard” medication for treating opioid addiction.

Every overdose death is PREVENTABLE.

Sound the ALARM !

Contact Your Kentucky legislators and ask them to support the ALARM Act.

(800) 372-7181 Monday-Friday 7am to 6pm

or

(502) 564-8100 Monday-Friday 8am to 4:30pm,

And email addresses can be found on their individual bio pages:

Senators

Representatives

Ask them to help save lives by joining you in supporting the Kentucky ALARM Act.

James Patrick Murphy, MD, DFASAM

Email: doctormurphyglms@gmail.com

Nora, we adore ya!

On September 20, 2024, NIDA Director, Dr. Nora Volkow, gave the keynote address at UofL’s Research!Louisville awards ceremony. Here’s some of what our nation’s top addiction researcher had to say…

The opioid crisis started more than two decades ago, and we have not solved it.

It has caused more people dying than COVID itself.

The people that have died from the opioid crisis, all of them could have been prevented. Every single one of them could have been prevented.

We know how to prevent an overdose.

Overdoses are happening throughout all of the ages, throughout the whole life span.

The rise in overdose crisis…they went up to 117,000 in one year, those numbers were driven predominantly by fentanyl

We are seeing the decreases in fentanyl overdoses…the latest numbers are twelve percent (decrease).

Pain medications started the overdose crisis. It basically stabilized and it’s going down.

Similarly, heroin basically is accounting for a very very limited amount of overdoses. And this reflects the fact that the drug dealers actually don’t see any benefit for them, incentive for them, selling heroin. They sell fentanyl.

What has created the turn down of the curve (in overdoses)?

This is what’s likely to be accounting for it… In the field of opioid use disorder, which is different from actually any other field in the substance use disorders, we have extremely effective medications.

To start with, we have an incredible drug, naloxone. Naloxone is an opioid receptor antagonist.

When you give it (naloxone) to someone that overdoses, you reverse that overdose if they overdosed with an opioid…Whether it is fentanyl or heroin or an opioid medication, you need to give the naloxone, for it to be effective, rapidly and at the correct dose.

We are very lucky to have naloxone.

And then we have three different classes of medications, all targeting the opioid receptor system, but with different pharmacological effects, that are very effective in treating opioid use disorders.

Methadone…It has been in existence for, I think, sixty years.

Buprenorphine was approved at the beginning of the 2000s.

And then we have naltrexone, that was approved for opioid use disorder more recently.

Methadone – full agonist at the opioid receptor.

Buprenorphine – partial agonist.

These medications (methadone and buprenorphine) are effective in reducing drug taking, in reducing craving, in reducing withdrawal.

Except for naltrexone.  Naltrexone does not, per se, reduce withdrawal, it reduces craving, and it improves mood.

They are very effective in preventing overdose.

So the challenge is, you say, if you have these medications that are being so effective, why are we having so many people dying of overdoses? And the answer is because we do have the medications, but they are not being given to those that need them.  

Why are they not being used?

There are  multiple issues.

A key one is the stigma and discrimination against addiction.

The healthcare system providers don’t want to treat people with a substance use disorder.

We have generated a specialized system for the treating of substance use disorders that is independent of the healthcare system. Which is a totally lost opportunity.

Across the continuum, how can we improve access to these medications for people that need them?

There’s no evidence, to my knowledge, that any of the harm reduction practices exacerbate or increase the rate of overdose. I don’t know of any evidence. On the other hand, there’s ample evidence to show that harm reduction practices significantly reduces mortality.

There was so much expectation that the removal of the (DEA) waiver would increase the number of practitioners prescribing buprenorphine, but it hasn’t happened. What the research has shown is that the number of prescribers giving buprenorphine has not increased very much…Restrictive practices don’t help…The issue to me, this is discrimination. There is discrimination also in the way that we set up the reimbursement of taking care of someone with a very complex and potentially fatal disease.

Thank you, Dr. Volkow. You knocked it out of the park!

And this statement by our NIDA Director bears repeating, because it is a call to action: “If you have these medication that are being so effective, why are we having so many people dying of overdoses? And the answer is because we do have the medications, but they are not being given to those that need them.

A CAPITOL idea! Governor Beshear proclaims September as Recovery Month in Kentucky!

Screenshot

On Monday 9/16/2024, under a brilliant baking sun, from the south lawn of the state Capitol, Governor Andy Beshear proclaimed September to be Recovery Month in Kentucky. To his left and to his right sat about twelve sun-drenched dignitaries, most wearing business attire meant for air-conditioned offices.  As I stood there in the front row, myself baking in the sun, I realized two things early on: (1) I had made the right decision to come, and (2) my game time decision to wear my UofL Med School polo shirt instead of a coat and tie was the right move (Can you find me in the pic below?).

Screenshot

I’d never heard Governor Beshear speak in person, and I found him to be as charming, personable, likable, and relatable as he always appears to be on TV. The governor said all the right things that needed to be said. He was inspirational as he recounted the work that had been done by Kentucky’s government over the past year battling the opioid crisis in our state. He touted KY’s 9.8% drop in overdose deaths from a year ago. He also said “There is a lot of work left to do.”

Eric Friedlander, Secretary of KY’s Cabinet for Health and Family Services also spoke and said he is thankful he is working for a Governor who “believes in science.”

And Lisa Lee, Commissioner for the Dept. for Medicaid, said that we’ve made progress, but she won’t be satisfied “until all barriers to treatment are gone.”

Others eloquently spoke, bills were ceremoniously signed, a few people with lived experience offered their compelling stories to the crowd, which dwindled a bit over time as onlookers gradually receded into the few shady spots farther away from the podium. All in all, the message was very positive. And as I stood in the front row to the right of the stage, facing Representative Kim Moser, the only other person besides me wearing red in Frankfort that day, I really wanted to believe the Governor when he said in closing, “I am convinced that we can defeat this epidemic.”

After the speeches, Representative Moser visited with me, offered me some of her views, gave me a little advice, and graciously invited me to come back to Frankfort in October to testify before her colleagues. She also introduced me to Secretary Friedlander, who I chatted with briefly. And before I left the podium area I got to speak with a true KY hero, Van Ingram, Executive Director for the Kentucky Office of Drug Control Policy.

These were all great connections to make. I had travelled to Frankfort thinking my main objective was to meet some of the people who I’ve been emailing regularly about the urgent need for a major overhaul of KY’s outdated and harmful regulation governing how physicians prescribe buprenorphine to treat addiction. I felt that my meet-and-greet mission had been accomplished. I could now report back to my organizations (i.e., KYSAM, ASAM, AMA, KYHRC) that our concerns about the buprenorphine regulation were probably a little closer to getting heard by the people who could bring about the needed change.

What happened next was unexpected.

I walked to the far end of the road between the Capitol and the Annex Building where dozens of addiction treatment, addiction recovery, and addiction support groups had set up tents, tables, and booths. I decided to visit every group represented there. I learned what they did, how they were funded, what role they played in the orchestra of helpers throughout our state. I met some amazing people, and I am definitely going to follow up with as many as I can. We truly have some fantastic advocates and caregivers in our state. 

And maybe providence had a plan for me that day, because as I worked my way along that road from the far end to the beginning, near the humongous, beautiful, and famous floral clock on the Capitol grounds, the last group I visited was comprised of only two women. Out of respect for their privacy, I won’t go into specifics. But suffice it to say, these two amazing individuals were living fulfilling lives in recovery from opioid addiction, both were being treated with buprenorphine, and both told me that treatment with buprenorphine had literally saved each of their lives. 

With this as my send off, I left the Capitol a little more sunburned but tremendously more inspired. It’s clear, there are a lot of wonderful people in our state doing fantastic things to help people with addiction make it to their promised land of recovery. And I’m  more determined than ever to prove myself worthy of inclusion amongst the ranks of these dedicated and compassionate healers, by virtue of my doctoring, my advocacy, and my caring. 

If you’ve read all the way down to this point in my article, then you are likely one of those wonderful people I mentioned in the paragraph above – because I know my writing is nowhere near as compelling as the cause. And you’re probably a person who wants to make a difference – maybe even save a life in the process. If so, then I have an ask of you…

Please help me get the message to our Governor that Kentucky’s outdated buprenorphine regulation needs to be gone. The science, the data, and the lived experience of thousands in recovery confirm that buprenorphine treatment for opioid addiction promotes recovery, prevents overdoses, and saves lives. I made some handouts that I gave to people at the Recovery Month event on the Capitol lawn. Below you will find screen shots of the handouts. 

As I said to one nice young lady, who politely told me that because she was employed by the state there was no way she could advocate for changing a state regulation, “That’s all right. I’m just asking that you read it.”

“Why?” she asked.

“Because, once you read it, you can’t un-read it.”

So, now I humbly ask you to please read the information below. And if you want to help remove a significant barrier to people with addiction receiving the most effective treatment we have to prevent overdoses and promote recovery, then stoke your creativity, ingenuity, determination, and problem-solving skills and help me find a way to get this information to Governor Beshear.

As Secretary Friedlander said, our Governor believes science. 

Once he reads this, he can’t un-read it.

And he will know what to do.

Your grateful colleague,

James Patrick Murphy, MD